GEHC
GE HealthCare Technologies Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$68.86
−1.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 20.2B | 20.6B | 19.7B | 19.6B | 18.3B |
| Cost of Revenue | 11.6B | 12.4B | 11.5B | 11.6B | 11.2B |
| Gross Profit | 8.7B | 8.2B | 8.2B | 7.9B | 7.2B |
| Operating Expenses | |||||
| R&D Expense | 1.3B | 1.3B | 1.3B | 1.2B | 1.0B |
| SG&A Expense | 4.3B | 4.2B | 4.3B | 4.3B | 3.6B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 478.0M | — | — | — | — |
| Total Operating Expenses | 6.1B | 5.5B | 5.6B | 5.5B | 4.7B |
| Cost and Expenses | 17.7B | 17.9B | 17.0B | 17.1B | 15.8B |
| Operating Income (EBIT) | 2.6B | 2.8B | 2.6B | 2.4B | 2.5B |
| Non-Operating | |||||
| Interest Income | (6.0M) | — | — | 26.0M | — |
| Interest Expense | 436.0M | 450.0M | 505.0M | 542.0M | 86.0M |
| Net Interest Income | (442.0M) | (450.0M) | (505.0M) | (516.0M) | (86.0M) |
| Other Non-Op Income/Expense | (528.0M) | 6.0M | (44.0M) | (74.0M) | (10.0M) |
| Non-Operating Income (excl Interest) | 105.0M | (445.0M) | (461.0M) | (468.0M) | (10.0M) |
| EBT (Pre-Tax Income) | 2.0B | 2.8B | 2.6B | 2.4B | 2.5B |
| Income Tax Expense | 446.0M | 614.0M | 531.0M | 743.0M | 563.0M |
| Bottom Line | |||||
| Net Income | 1.6B | 2.1B | 2.0B | 1.6B | 1.9B |
| Earnings from Cont. Ops | 1.6B | 2.2B | 2.0B | 1.6B | 1.9B |
| Earnings from Discont. Ops | — | — | — | (4.0M) | 18.0M |
| Bottom Line Net Income | 1.6B | 2.1B | 2.0B | 1.4B | 1.9B |
| Per Share | |||||
| Basic EPS | $3.48 | $4.56 | $4.37 | $3.04 | $4.22 |
| Diluted EPS | $3.45 | $4.55 | $4.34 | $3.02 | $4.22 |
| Revenue Per Share | $44.69 | $45.18 | $43.14 | $42.97 | $40.41 |
| Shares | |||||
| Basic Shares Outstanding | 453.0M | 456.5M | 456.0M | 455.0M | 453.9M |
| Diluted Shares Outstanding | 454.0M | 460.3M | 459.0M | 458.0M | 453.9M |
| Profitability Metrics | |||||
| EBITDA | 3.5B | 3.8B | 3.7B | 3.5B | 3.2B |
| D&A | 1.0B | 578.0M | 580.0M | 610.0M | 633.0M |
| EBIT | 2.5B | 3.2B | 3.1B | 2.9B | 2.5B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026